Search research articles
Contact Us
Filters
Showing results (151-160 of 268) with videos related to
Page
of 27
Sort By:
Medicinal Research Reviews
|
May 1, 1995
Phospholipid antitumor agents
W J Houlihan, M Lohmeyer, P Workman, et al.
British Journal of Cancer
|
January 1, 1985
The effect of systemic hyperthermia on melphalan pharmacokinetics in mice
D J Honess, J Donaldson, P Workman, et al.
Psychopharmacologia
|
January 1, 1971
Drug effects on distress-evoked behavior in mice: methodology and drug class comparisons
S Irwin, R Kinoi, M Van Sloten, et al.
Biochemical Pharmacology
|
November 16, 2001
Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential
P A Clarke, R te Poele, R Wooster, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinones
S M Bailey, N Suggett, M I Walton, et al.
British Journal of Cancer
|
November 1, 1989
DT-diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs?
P Workman, M I Walton, G Powis, et al.
Cancer Chemotherapy and Pharmacology
|
April 2, 1998
Geldanamycin-induced cytotoxicity in human colon-cancer cell lines: evidence against the involvement of c-Src or DT-diaphorase
V G Brunton, G Steele, A D Lewis, et al.
Neurobiology of Aging
|
October 26, 2021
Sex differences in cognitive aging: a 4-year longitudinal study in marmosets
Emily S Rothwell, Kathryn P Workman, Dongwei Wang, et al.
Biochemical Pharmacology
|
January 7, 1998
Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554)
E O Aboagye, A D Lewis, M Tracy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1988
Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)
H F Newman, N M Bleehen, R Ward, et al.
Page
of 27
Search research articles
Search
Showing results (151-160 of 268) with videos related to
Sort By:
Page
of 27
Medicinal Research Reviews
|
May 1, 1995
Phospholipid antitumor agents
W J Houlihan, M Lohmeyer, P Workman, et al.
British Journal of Cancer
|
January 1, 1985
The effect of systemic hyperthermia on melphalan pharmacokinetics in mice
D J Honess, J Donaldson, P Workman, et al.
Psychopharmacologia
|
January 1, 1971
Drug effects on distress-evoked behavior in mice: methodology and drug class comparisons
S Irwin, R Kinoi, M Van Sloten, et al.
Biochemical Pharmacology
|
November 16, 2001
Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential
P A Clarke, R te Poele, R Wooster, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinones
S M Bailey, N Suggett, M I Walton, et al.
British Journal of Cancer
|
November 1, 1989
DT-diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs?
P Workman, M I Walton, G Powis, et al.
Cancer Chemotherapy and Pharmacology
|
April 2, 1998
Geldanamycin-induced cytotoxicity in human colon-cancer cell lines: evidence against the involvement of c-Src or DT-diaphorase
V G Brunton, G Steele, A D Lewis, et al.
Neurobiology of Aging
|
October 26, 2021
Sex differences in cognitive aging: a 4-year longitudinal study in marmosets
Emily S Rothwell, Kathryn P Workman, Dongwei Wang, et al.
Biochemical Pharmacology
|
January 7, 1998
Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554)
E O Aboagye, A D Lewis, M Tracy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1988
Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)
H F Newman, N M Bleehen, R Ward, et al.
Page
of 27